Annual EBIT
-$22.06 M
+$9.71 M+30.57%
31 December 2023
Summary:
Cardiol Therapeutics annual earnings before interest & taxes is currently -$22.06 million, with the most recent change of +$9.71 million (+30.57%) on 31 December 2023. During the last 3 years, it has fallen by -$6.62 million (-42.85%). CRDL annual EBIT is now -1686.31% below its all-time high of -$1.19 million.CRDL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.36 M
-$4.71 M-83.20%
30 September 2024
Summary:
Cardiol Therapeutics quarterly earnings before interest & taxes is currently -$10.36 million, with the most recent change of -$4.71 million (-83.20%) on 30 September 2024. Over the past year, it has dropped by -$4.66 million (-81.64%). CRDL quarterly EBIT is now -2428.55% below its all-time high of -$409.80 thousand, reached on 01 September 2017.CRDL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$28.15 M
-$4.66 M-19.83%
30 September 2024
Summary:
Cardiol Therapeutics TTM earnings before interest & taxes is currently -$28.15 million, with the most recent change of -$4.66 million (-19.83%) on 30 September 2024. Over the past year, it has dropped by -$5.30 million (-23.19%). CRDL TTM EBIT is now -6768.69% below its all-time high of -$409.80 thousand, reached on 01 September 2017.CRDL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.6% | -81.6% | -23.2% |
| 3 y3 years | -42.9% | -28.4% | -1.4% |
| 5 y5 years | -87.7% | -292.0% | -92.2% |
CRDL EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -42.9% | +30.6% | -120.7% | +0.3% | -27.6% | +20.6% |
| 5 y | 5 years | -114.0% | +30.6% | -351.5% | +0.3% | -186.1% | +20.6% |
| alltime | all time | -1686.3% | +30.6% | -2428.6% | +0.3% | -6768.7% | +20.6% |
Cardiol Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.36 M(+83.2%) | -$28.15 M(+19.8%) |
| June 2024 | - | -$5.66 M(-9.2%) | -$23.49 M(+4.3%) |
| Mar 2024 | - | -$6.23 M(+5.7%) | -$22.53 M(+2.2%) |
| Dec 2023 | -$22.06 M(-30.6%) | -$5.90 M(+3.4%) | -$22.05 M(-3.5%) |
| Sept 2023 | - | -$5.70 M(+21.5%) | -$22.85 M(-16.2%) |
| June 2023 | - | -$4.69 M(-18.4%) | -$27.27 M(-8.5%) |
| Mar 2023 | - | -$5.75 M(-14.1%) | -$29.80 M(-6.2%) |
| Dec 2022 | -$31.77 M(+3.0%) | -$6.70 M(-33.9%) | -$31.77 M(-10.4%) |
| Sept 2022 | - | -$10.12 M(+40.1%) | -$35.46 M(+6.2%) |
| June 2022 | - | -$7.22 M(-6.5%) | -$33.41 M(+6.3%) |
| Mar 2022 | - | -$7.72 M(-25.7%) | -$31.41 M(+2.1%) |
| Dec 2021 | -$30.84 M | - | - |
| Dec 2021 | - | -$10.39 M(+28.8%) | -$30.78 M(+10.8%) |
| Sept 2021 | - | -$8.07 M(+54.3%) | -$27.77 M(+20.7%) |
| June 2021 | - | -$5.23 M(-26.2%) | -$23.01 M(+13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$7.09 M(-4.0%) | -$20.36 M(+30.8%) |
| Dec 2020 | -$15.44 M(+49.8%) | -$7.38 M(+123.0%) | -$15.57 M(+48.2%) |
| Sept 2020 | - | -$3.31 M(+28.0%) | -$10.51 M(+6.8%) |
| June 2020 | - | -$2.59 M(+12.7%) | -$9.84 M(-1.4%) |
| Mar 2020 | - | -$2.29 M(-1.0%) | -$9.98 M(-3.2%) |
| Dec 2019 | -$10.31 M(-12.3%) | -$2.32 M(-12.3%) | -$10.31 M(-29.6%) |
| Sept 2019 | - | -$2.64 M(-2.9%) | -$14.65 M(-5.8%) |
| June 2019 | - | -$2.72 M(+3.7%) | -$15.56 M(+12.7%) |
| Mar 2019 | - | -$2.62 M(-60.6%) | -$13.80 M(+19.0%) |
| Dec 2018 | -$11.75 M(+851.7%) | -$6.66 M(+87.5%) | -$11.60 M(+115.2%) |
| Sept 2018 | - | -$3.55 M(+266.5%) | -$5.39 M(+139.7%) |
| June 2018 | - | -$968.80 K(+129.6%) | -$2.25 M(+75.7%) |
| Mar 2018 | - | -$422.00 K(-5.8%) | -$1.28 M(+49.2%) |
| Dec 2017 | -$1.23 M | -$448.00 K(+9.3%) | -$857.80 K(+109.3%) |
| Sept 2017 | - | -$409.80 K | -$409.80 K |
FAQ
- What is Cardiol Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual EBIT year-on-year change?
- What is Cardiol Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly EBIT year-on-year change?
- What is Cardiol Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM EBIT year-on-year change?
What is Cardiol Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CRDL is -$22.06 M
What is the all time high annual EBIT for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual earnings before interest & taxes is -$1.19 M
What is Cardiol Therapeutics annual EBIT year-on-year change?
Over the past year, CRDL annual earnings before interest & taxes has changed by +$9.71 M (+30.57%)
What is Cardiol Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CRDL is -$10.36 M
What is the all time high quarterly EBIT for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly earnings before interest & taxes is -$409.80 K
What is Cardiol Therapeutics quarterly EBIT year-on-year change?
Over the past year, CRDL quarterly earnings before interest & taxes has changed by -$4.66 M (-81.64%)
What is Cardiol Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CRDL is -$28.15 M
What is the all time high TTM EBIT for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM earnings before interest & taxes is -$409.80 K
What is Cardiol Therapeutics TTM EBIT year-on-year change?
Over the past year, CRDL TTM earnings before interest & taxes has changed by -$5.30 M (-23.19%)